Jared has 12+ years experience in biotech within scientific, quality, and regulatory roles. At NMDP, he oversees regulatory CMC and strategy functions for cell & gene therapy programs, focusing on procurement of cellular starting materials. Formerly, he worked as a scientist at a CRO offering assay development and biomarker validation services under CLIA. His academic work at the University of Minnesota focused on development anti-inflammatory therapies for chronic viral infections. Jared is an active member of ASCP, AABB, RAPS, ASGCT and ISCT. He holds degrees in Molecular Genetics and Pharmacology, and is a certified Histotechnologist (ASCP) and Advanced Biotherapies Professional (AABB).